Nigel Titford

Company: BioGaia

Job title: CEO@ BioGaia Pharma AB & Head of BD @ BioGaia AB

Seminars:

Probiotic & Therapeutic Development Cross-Talk: Defining a Route Forward with Therapeutic & Commercial Potential in Mind 2:30 pm

How to leverage expertise and IP landscape awareness to de-risk drug opportunities at an early stage Approach to select probiotic clinical / preclinical research programmes to move into a therapeutic setting, or remain within probiotic BioGaia Pharma’s pharma pipeline, and approach to de-risking opportunities for internal or external developmentRead more

day: Conference Day One